Patents by Inventor Ian Garnett

Ian Garnett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250145574
    Abstract: The present invention provides a compound represented by formula (I), a production method thereof, a production intermediate of the same and a method for producing compound B using the compound (I). Compound B is useful as an intermediate for producing compound A that is a BTK inhibitor.
    Type: Application
    Filed: February 10, 2022
    Publication date: May 8, 2025
    Applicant: CARNA BIOSCIENCES, INC.
    Inventors: Wataru KAWAHATA, Ian GARNETT, Tomohiro SHIMIZU, Takayuki IRIE
  • Publication number: 20220324890
    Abstract: The present invention provides cromakalim prodrugs, compositions, and their use for the modulation of ATP-sensitive potassium (KATP) channels for therapeutic purposes.
    Type: Application
    Filed: June 9, 2022
    Publication date: October 13, 2022
    Inventors: Thurein M. Htoo, Barbara M. Wirostko, Michael P. Fautsch, Ian Garnett, Chiara Massarenti
  • Publication number: 20120165520
    Abstract: The present invention provides a process for the synthesis of opioid prodrugs. In particular, the present invention provides a process for the synthesis of opioid prodrugs comprising: treating an opioid, in the form of a salt or a freebase, with a carbonyl synthon to form an activated intermediate and subsequently reacting the activated intermediate with an amine, in the form of a salt or a freebase.
    Type: Application
    Filed: December 22, 2011
    Publication date: June 28, 2012
    Inventors: Paul McGee, Ian Garnett, E. Juan, A. Manage, Jean-Francois Carniaux